Literature DB >> 20537357

CLOVES syndrome with thoracic and central phlebectasia: increased risk of pulmonary embolism.

Ahmad I Alomari1, Patricia E Burrows, Edward Y Lee, Daniel J Hedequist, John B Mulliken, Steven J Fishman.   

Abstract

OBJECTIVE: CLOVES syndrome (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal/scoliosis and spinal abnormalities) is a rare, complex overgrowth syndrome with serious morbidity. In this communication we studied the presence of central and thoracic phlebectasia in patients with CLOVES syndrome and its clinical implications.
METHODS: We conducted a comprehensive search of our databases at Children's Hospital Boston over the last 10 years (1999-2008) for patients with CLOVES syndrome and central and thoracic phlebectasia. Medical records, clinical photographs, and imaging studies of varying modalities were reviewed.
RESULTS: Review of the clinical data and imaging studies of 12 patients with CLOVES syndrome documented the presence of central and thoracic phlebectasia in 11 patients. Two patients had serious perioperative pulmonary embolism, and 1 died.
CONCLUSIONS: Central and thoracic phlebectasia in patients with CLOVES syndrome is common and increases the risk of pulmonary embolism. Aggressive prophylactic measures should be considered before major interventions. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537357     DOI: 10.1016/j.jtcvs.2010.04.023

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  CLOVES Syndrome: Severe Neonatal Presentation.

Authors:  Silvana Acosta; Viviana Torres; María Paulos; Ignacio Cifuentes
Journal:  J Clin Diagn Res       Date:  2017-04-01

2.  Characterization of thrombosis in patients with Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay N Lozier; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

3.  PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.

Authors:  Kim M Keppler-Noreuil; Jonathan J Rios; Victoria E R Parker; Robert K Semple; Marjorie J Lindhurst; Julie C Sapp; Ahmad Alomari; Marybeth Ezaki; William Dobyns; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2014-12-31       Impact factor: 2.802

Review 4.  Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies.

Authors:  Kim M Keppler-Noreuil; Victoria E R Parker; Thomas N Darling; Julian A Martinez-Agosto
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-18       Impact factor: 3.908

5.  Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.

Authors:  Kyle C Kurek; Valerie L Luks; Ugur M Ayturk; Ahmad I Alomari; Steven J Fishman; Samantha A Spencer; John B Mulliken; Margot E Bowen; Guilherme L Yamamoto; Harry P W Kozakewich; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2012-05-31       Impact factor: 11.025

6.  Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.

Authors:  Kim M Keppler-Noreuil; Julie C Sapp; Marjorie J Lindhurst; Victoria E R Parker; Cathy Blumhorst; Thomas Darling; Laura L Tosi; Susan M Huson; Richard W Whitehouse; Eveliina Jakkula; Ian Grant; Meena Balasubramanian; Kate E Chandler; Jamie L Fraser; Zoran Gucev; Yanick J Crow; Leslie Manace Brennan; Robin Clark; Elizabeth A Sellars; Loren D M Pena; Vidya Krishnamurty; Andrew Shuen; Nancy Braverman; Michael L Cunningham; V Reid Sutton; Velibor Tasic; John M Graham; Joseph Geer; Alex Henderson; Robert K Semple; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2014-04-29       Impact factor: 2.802

7.  A Neonate with CLOVES Syndrome.

Authors:  Dilek Sarici; Mustafa Ali Akin; Selim Kurtoglu; Filiz Tubas; Serdar Umit Sarici
Journal:  Case Rep Pediatr       Date:  2014-10-22

Review 8.  Venous Thromboembolism in Pediatric Vascular Anomalies.

Authors:  Taizo A Nakano; Chadi Zeinati
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

9.  Somatic frameshift mutation in PIK3CA causes CLOVES syndrome by provoking PI3K/AKT/mTOR pathway.

Authors:  Wei Yan; Bin Zhang; Huijun Wang; Ran Mo; Xingyuan Jiang; Wen Qin; Lin Ma; Zhimiao Lin
Journal:  Hereditas       Date:  2021-06-01       Impact factor: 3.271

10.  Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome.

Authors:  Kim M Keppler-Noreuil; Jay Lozier; Neal Oden; Anjali Taneja; Jasmine Burton-Akright; Julie C Sapp; Leslie G Biesecker
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-09-06       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.